Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for Headache Prophylaxis in Adolescents with Chronic Migraine
NCT01662492Phase 3Completed
- Sponsor
- Allergan
- Start
- Oct 2012
- Primary completion
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of onabotulinumtoxinA in chronic migraine, sponsored by Allergan. Started Oct 2012; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT01662492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01662492.